SCHEMBL18975189

SCHEMBL18975189

O=C(O)CN1CCN(CC(=O)O)CCN(CC(O)CN(CC(=O)O)Cc2ccccc2)CCN(CC(=O)O)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
POLB P06746 2/20 0.44
BACE1 P56817 4/20 0.43
KDM4E B2RXH2 1/20 0.41
PRMT5 O14744 2/20 0.40
WDR77 Q9BQA1 2/20 0.40
HSD17B10 Q99714 1/20 0.40
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
SLC6A9 P48067 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
TSHR P16473 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5557205 0.94 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1POLBBACE1
SCHEMBL22446610 0.89 POLB (0.42) ALDH1A1KMT2AMEN1POLBBACE1
SCHEMBL18975211 0.88 BACE1 (0.48) ALDH1A1KMT2AMEN1BACE1KDM4E
SCHEMBL18975269 0.85 BACE1 (0.45) ALDH1A1KMT2AMEN1POLBBACE1
SCHEMBL3113817 0.85 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1POLBKDM4E
SCHEMBL18970104 0.84 HSD17B10 (0.38) ALDH1A1KMT2AMEN1KDM4EHSD17B10
SCHEMBL18975218 0.82 POLB (0.42) ALDH1A1KMT2AMEN1POLBBACE1
SCHEMBL18970111 0.81 TDP1 (0.39) ALDH1A1KMT2AMEN1BACE1KDM4E
SCHEMBL18970241 0.81 SLC6A9 (0.36) ALDH1A1KMT2AMEN1KDM4EHSD17B10
SCHEMBL18975286 0.81 ALDH1A1 (0.41) ALDH1A1KMT2AMEN1POLBBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11021451-B2 Contrast agents BRACCO IMAGING S.P.A. (IT) 2021-06-01 US disclosed
EP-3386953-B1 CONTRAST AGENTS BRACCO IMAGING SPA (IT) 2020-10-21 EP disclosed
US-20200325108-A1 CONTRAST AGENTS BRACCO IMAGING S.P.A. (IT) 2020-10-15 US disclosed
US-10781188-B2 Contrast agents BRACCO IMAGING S.P.A. (IT) 2020-09-22 US disclosed
WO-2017098038-A1 CONTRAST AGENTS BRACCO IMAGING SPA (IT) 2017-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11021451-B2 Contrast agents SLC39A14, ABCB7, SLC40A1 ALDH1A1 4417/4885KMT2A 3006/4885MEN1 323/4885
US-20200325108-A1 CONTRAST AGENTS SLC39A14, ABCB7, SLC40A1 ALDH1A1 4417/4885KMT2A 3006/4885MEN1 323/4885
US-10781188-B2 Contrast agents SLC39A14, ABCB7, SLC40A1 ALDH1A1 4417/4885KMT2A 3006/4885MEN1 323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.